Layoffs at Galapagos
- Layoff events
- 4
- verified and sourced
- Roles reported
- 865
- roles in total
- Announced between
- Oct 2023 to Oct 2025
- Reported by
- Galapagos / U.S. Securities and Exchange Commission, Galapagos, BioSpace, and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Galapagos: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Galapagos |
Site closure
Galapagos announced its intention to wind down its cell-therapy business after failing to secure a viable buyer, a plan affecting approximately 365 employees and five sites across Europe, the United States and China. |
365 | Not known | Leiden + Basel + Princeton + Pittsburgh + Shanghai | ||
| Galapagos |
Restructuring
Galapagos announced a strategic reorganization tied to its planned separation into two companies, anticipating a reduction of approximately 300 positions across Europe. |
300 | Not known | Company-wide | ||
| Galapagos |
Restructuring
Galapagos disclosed that it had streamlined operations and reduced around 100 positions while refocusing its portfolio. |
100 | Not known | Company-wide |
1 source for Galapagos |
|
| Galapagos |
Restructuring
Galapagos announced approximately 100 job cuts alongside the transfer of roughly 400 Jyseleca-focused employees to Alfasigma. |
100 | Not known | Company-wide |
1 source for Galapagos |
Where this comes from
Every cut listed for Galapagos was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Galapagos? Tell us on our Discord and we will check it.